Acusensus Ltd (AU:ACE)
ASX:ACE
Want to see AU:ACE full AI Analyst Report?
Top Page
Acusensus Ltd
(Sydney:ACE)
Select Model
Select Model
Rating:49Neutral
Price Target:
AU$1.50
▼(-7.41% Downside)
Action:Reiterated
Date:11/19/25
Acusensus Ltd's stock score is primarily impacted by its financial performance challenges, particularly in profitability and cash flow management. Technical analysis shows some positive momentum, but valuation concerns due to a negative P/E ratio weigh heavily on the overall score.
Positive Factors
Consistent revenue growth
Sustained revenue growth demonstrates continued demand for detection solutions and expanding program rollouts. Over 2-6 months this underpins potential operating leverage as fixed costs are absorbed, creating a pathway to improved margins if cost discipline and scale in recurring services continue.
Negative Factors
Ongoing negative margins
Persistent negative EBIT and net margins signal structural cost or pricing issues that limit the firm's ability to generate shareholder returns. Unless operational efficiencies or higher-margin recurring revenue mix materialize, profitability will remain a constraint on long-term value creation.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth
Sustained revenue growth demonstrates continued demand for detection solutions and expanding program rollouts. Over 2-6 months this underpins potential operating leverage as fixed costs are absorbed, creating a pathway to improved margins if cost discipline and scale in recurring services continue.
Read all positive factors
Acusensus Ltd (ACE) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$238.62M
Dividend YieldN/A
Average Volume (3M)361.88K
Price to Earnings (P/E)―
Beta (1Y)1.21
Revenue Growth31.98%
EPS Growth-1041.84%
CountryAU
Employees164
SectorTechnology
Sector Strength88
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)-0.17
Shares Outstanding169,235,550
10 Day Avg. Volume549,798
30 Day Avg. Volume361,885
Financial Highlights & Ratios
PEG Ratio-0.78
Price to Book (P/B)2.72
Price to Sales (P/S)2.14
P/FCF Ratio-17.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.40Price Target Upside48.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.04
Revenue Forecast (FY)AU$79.10M
Acusensus Ltd Business Overview & Revenue Model
Company Description
Acusensus Limited, an intelligent traffic solutions (ITS) technology company, designs, develops, and commercializes technology focuses on the detection of distracted drivers in Australia. It offers s Acusensus Heads Up solution used to detect and ...
How the Company Makes Money
Acusensus makes money primarily by providing road safety detection solutions to government road authorities and enforcement operators. Revenue is generated through (1) supplying or deploying detection hardware (camera/sensor units and related equi...
Acusensus Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.84M | 59.35M | 49.63M | 42.00M | 28.65M | 6.27M |
| Gross Profit | 14.17M | 26.57M | 22.58M | 4.61M | 3.21M | -1.18M |
| EBITDA | -16.68M | 3.89M | 5.33M | 5.35M | 4.38M | -2.97M |
| Net Income | -22.93M | -2.62M | -1.52M | 55.37K | 1.43M | -3.65M |
Balance Sheet | ||||||
| Total Assets | 99.28M | 73.53M | 48.69M | 48.46M | 26.16M | 19.57M |
| Cash, Cash Equivalents and Short-Term Investments | 40.95M | 21.45M | 19.34M | 24.80M | 8.61M | 12.33M |
| Total Debt | 12.14M | 7.93M | 2.19M | 2.19M | 2.33M | 977.62K |
| Total Liabilities | 43.22M | 26.73M | 12.77M | 12.54M | 9.40M | 4.50M |
| Stockholders Equity | 56.06M | 46.79M | 35.92M | 35.92M | 16.76M | 15.07M |
Cash Flow | ||||||
| Free Cash Flow | -13.57M | -7.23M | -3.94M | -1.12M | -2.28M | -3.85M |
| Operating Cash Flow | 3.25M | 8.27M | 3.58M | 4.26M | 4.97M | -1.00M |
| Investing Cash Flow | 1.41M | -13.71M | -7.52M | -17.37M | -7.24M | -3.17M |
| Financing Cash Flow | 26.40M | 9.25M | -1.47M | 17.34M | -1.44M | 15.38M |
Acusensus Ltd Technical Analysis
Negative
1.62
Price Trends
1.49
Negative
1.58
Negative
1.51
Negative
Market Momentum
-0.04
Positive
40.45
Neutral
44.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ACE, the sentiment is Negative. The current price of 1.62 is above the 20-day moving average (MA) of 1.45, above the 50-day MA of 1.49, and above the 200-day MA of 1.51, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 40.45 is Neutral, neither overbought nor oversold. The STOCH value of 44.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ACE.
Acusensus Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | AU$14.89M | -1.21 | -15.64% | ― | -19.91% | 35.34% | |
49 Neutral | AU$238.62M | -2.91 | -44.58% | ― | 31.98% | -1041.84% | |
45 Neutral | AU$42.44M | -17.78 | -64.64% | 4.99% | -63.89% | -609.31% | |
45 Neutral | AU$6.80M | -2.39 | -658.94% | ― | 2.54% | 56.90% | |
42 Neutral | AU$3.89M | -0.75 | -53.27% | ― | 5.00% | -1714.29% |
* Technology Sector Average
AU:ACE
Acusensus Ltd
1.36
0.36
35.50%
AU:FCT
FirstWave Cloud Technology
0.01
-0.01
-50.00%
AU:SEN
Senetas Corporation Limited
2.50
0.59
30.89%
AU:KNO
Knosys Ltd.
0.02
-0.02
-45.45%
AU:WHK
WhiteHawk Ltd.
0.01
-0.01
-50.00%
Acusensus Ltd Corporate Events
Acusensus flags director interest change as it expands global road safety push
May 11, 2026
Acusensus Ltd has notified the market of a change in a director’s interests via an Appendix 3Y filing, in line with ASX Listing Rule 3.19A.2 requirements. The announcement underscores the company’s adherence to continuous disclosure ob...
Acusensus expands capital base with conversion of unquoted securities
May 11, 2026
Acusensus Ltd has notified the market of the issue of 510,660 new ordinary fully paid shares following the exercise or conversion of previously unquoted options or other convertible securities. The new shares, issued on 11 May 2026 and disclosed v...
Acusensus applies to quote new employee incentive shares on ASX
May 8, 2026
Acusensus Ltd has applied for quotation on the ASX of 510,660 ordinary fully paid shares issued under its employee incentive scheme, with the new securities to be quoted from 11 May 2026. The additional quoted shares expand the company’s fre...
Acusensus Reaffirms FY26 Outlook as Global Road Safety Programs Accelerate
May 5, 2026
Acusensus reaffirmed its FY26 guidance as it reported strong operational momentum, highlighted by a deepening U.S. sales pipeline, mobilisation of a statewide work zone speed enforcement program in Connecticut and ongoing investment to grow its Am...
Acusensus Reports Lapse of 11,903 Performance Rights
Apr 2, 2026
Acusensus Ltd has notified the market of the cessation of 11,903 performance rights, recorded under ASX security code ACEAAA, following their lapse on 31 March 2026. The rights expired because the conditions attached to them were not met or became...
Acusensus Added as S&P Dow Jones Confirms March 2026 All Ordinaries Rebalance
Mar 10, 2026
Acusensus Limited has been confirmed for inclusion in the SP/ASX All Ordinaries Index as part of SP Dow Jones Indices’ March 2026 quarterly rebalance, reinforcing its profile as a listed Australian road safety technology provider. The update...
S&P Dow Jones Indices Unveils March 2026 Rebalance of S&P/ASX Benchmarks
Mar 6, 2026
SP Dow Jones Indices has announced its March 2026 quarterly rebalance of the SP/ASX indices, reshuffling constituents across the 20, 50, 100, 200 and 300 benchmarks, effective before the market opens on 23 March. The changes bring Northern Star Re...
Acusensus Seeks ASX Quotation for New Employee Incentive Shares
Mar 2, 2026
Acusensus Ltd has applied for quotation of 240,164 ordinary fully paid shares on the ASX under its existing ticker ACE. The new securities, issued on 4 March 2026 under an employee incentive scheme, will be quoted and freely transferable, modestly...
Acusensus Wins $11.2m Expansion of WA Fixed Road Safety Enforcement Deal
Feb 25, 2026
Acusensus has expanded its fixed site multi-function enforcement agreement with Western Australia’s Road Safety Commission, adding new AI-enabled safety camera installations across the state from the second half of 2026 through 2027. The upg...
Acusensus grows revenue 40% but swings to deeper half-year loss on legal settlement
Feb 25, 2026
Acusensus reported a 40% increase in half-year revenue to $40.3 million for the period ended 31 December 2025, driven by new enforcement contracts in New Zealand and Western Australia, higher unit deployments in Queensland and continued growth in ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.